NCT03723564View on ClinicalTrials.gov

Serial Amnioinfusions As Regenerative Therapy for Pulmonary Hypoplasia

PHASE1RecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

October 1, 2018

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions
Renal Failure CongenitalCongenital Renal Anomaly NosRenal Agenesis and DysgenesisLower Urinary Tract Obstructive Syndrome
Interventions
DRUG

Lactated Ringers Solution for Injection

Using ultrasound guidance, a 22 gauge needle will be introduced into amniotic cavity. Warmed Lactated Ringers solution will be injected into the amniotic cavity until an AFI of 8.0 cm is achieved

Trial Locations (1)

55905

RECRUITING

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT03723564 - Serial Amnioinfusions As Regenerative Therapy for Pulmonary Hypoplasia | Biotech Hunter | Biotech Hunter